Simon Wu

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets.

Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets.

Journal: Leukemia

Published: October 09, 2025

Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma.

Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma.

Journal: International journal of molecular sciences

Published: June 07, 2025

Genomic variation in DDX41 identified through clinical sequencing.

Genomic variation in DDX41 identified through clinical sequencing.

Journal: British journal of haematology

Published: April 24, 2025

Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma.

Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma.

Journal: Current treatment options in oncology

Published: April 18, 2023

Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major.

Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major.

Journal: Vox sanguinis

Published: May 26, 2021

The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia.

The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia.

Journal: Leukemia & lymphoma

Published: April 26, 2021

Transposed-letter priming effects in reading aloud words and nonwords.

Transposed-letter priming effects in reading aloud words and nonwords.

Journal: Psychonomic bulletin & review

Published: February 11, 2015

Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study.

Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study.

Journal: Palliative & supportive care

Published: February 15, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026